Representatives of Brussels-based offices leading the work of Health Working Group.
ERRIN’s Health Working Group (WG) supports members with early intelligence and regular updates about EU-level health policy-related issues, regulations, EU programmes and their funding opportunities. Creating opportunities for interregional cooperation in the Health area is one of the WG’s main objectives. The WG is also a vehicle for networking, profile raising and promoting good practices and projects among health stakeholders in the ERRIN regions.
The topic of widening gathers high attention in the discussions around the next European Framework Programme for R&I, raising questions with the potential to influence not only the Widening sub-
The Health Working Group meeting will update colleagues on the European Commission’s initiatives linked to staff and skills shortages and training and up-skilling of the health workforce, exploring
ERRIN has been closely involved in the design and implementation of the EU Missions since their inception. Missions remain one of the network's priorities and were one of the four main areas of focus
The 2021 edition of the European Research and Innovation Days will take place as an online event this coming June.
Welcome to ERRIN Spring Annual General Meeting 2021! Taking place on 22 June just before the EU R&I Days, it will provide a great opportunity to exchange on the role and contribution of regional and local research and innovation ecosystems in the EU. The Spring AGM will also be a very special occasion as this year marks 20 years of ERRIN.
During an upcoming webinar in the frame of the DigitalHealthEurope project, in which ERRIN is a partner, Digital Innovation Hubs from Central-Eastern Europe will present their needs and ideas, boosting potential match-making and future partnerships.
At this event, Nordic capitals and capital regions will share best practices and highlight challenges in moving towards zero pollution in rural and urban areas.
The final event for the SAAM project will take place as an open conference on the subject of coaching technologies for wellbeing and care. The event will be live-streamed from 13:00 CEST on Wednesday 26 May.
Workshop on regional translational ecosystems supportive of Personalising Health Industry.
The ERRIN Year in review 2022 is out! Read the report to see the numerous activities ERRIN and its members have been involved in throughout the year.
Please find attached ERRIN and the network of European Regional and Local Health Authorities (EUREGHA)'s joint statement on the Horizon Europe Mission on Cancer.
Further to the Health WG meeting on the Cancer Mission, EUREGHA and ERRIN have decided to address the Cancer Mission Board with a statement to emphasise the role of regions in this mission.
Following the call for nominations for ERRIN Management Board held between 20 September and 5 October, we are happy to announce the nominated Management Board members. The five nominees will be approved as new Management Board members at the ERRIN Extraordinary General Meeting on 16 November.
In view of the annual strategy workshops that we will organise with all the Working Group (WG) and Task Force (TF) leaders in the second half of November, all members are invited to provide input on priorities, topics, and activities that should be addressed in 2024. The input can be provided by 31 October 2023.
On 19 September 2023, the European Commission published the list of actions that Member States and Associated Countries to Horizon Europe are so far undertaking or planning to undertake in support of one or more of the five flagships of the New European Innovation Agenda, including Flagship 3 closely followed by ERRIN. 20 countries have so far reported 169 actions in total, with their scope ranging from regional, through national to European.
Every year ERRIN holds elections for the Management Board. Becoming a member of the Board offers a great opportunity to develop ERRIN further and strategically lead the network’s activities. You can put forward your candidature for this year’s elections until 5 October.
Until 20 October 2023, 46 regions that have been identified as facing a sharp working-age population decline, in combination with a low and stagnating share of people with tertiary education and brain drain can apply for an open call for technical assistance under the Talent Booster Mechanism.
On 6 September, the European Commission published a matchmaking map showcasing European regions that have so far expressed their interest to become a Regional Innovation Valley (RIV) by applying to the call for Expression of Interest launched in March 2023. The call for EoI is still open for new submissions until 18 September 2023.
The Joint Programming Initiative (JPI) "More Years, Better Lives is organising an interactive, participatory workshop to discuss with experts what "good care and support” means and what role new technologies play into this notion.
As Belgium moves away from confinement, the ERRIN Secretariat has developed a new work policy with necessary safety measures in line with national guidelines for the coming months.
The European Innovation Council (EIC)'s Accelerator Pilot has awarded €166 million to 36 companies fighting the coronavirus pandemic.
The School of Business, Engineering and Science at Halmstad University invites one or several experienced researchers (has a Ph.D.) of any nationality to develop a collaborative MSCA Individual Fellowship application within the European Commission’s H2020 program. Applicants may not have resided, worked, or studied in Sweden for more than 12 months in the 3 years prior to the call deadline.
Can your region be an example of how the COVID-19 recovery has shifted priorities, putting the green transition and research and innovation at the core of your strategy? We encourage you to get in touch with us as we are looking for regional cases to feed into the policy debate.
The CY-Biobank Center of Excellence in Biobanking and Biomedical Research in Cyprus is looking to be part of a cohort/ consortium under the calls for proposals SC1-PHE-CORONAVIRUS-2020-2D and/or SC1-PHE-CORONAVIRUS-2020-2E.